Christopher Griffin, the Insta influencer 'Plant Kween,' joined Cheddar News this week to provide some tips for budding plant parents. Griffin goes in-depth on a number of plant-focused topics, including which species' might be best for beginners.
Share:
More In Science
Grindr Looks to Distribute 1 Million Free HIV Test Kits in New Initiative
The LGBTQ+ dating app Grindr is doing its part to snuff out the HIV epidemic by offering free at-home test kits to users.
FDA Approves Regeneron Cholesterol Drug Use For Children
The Food and Drug Administration expanded its approval of Regeneron's cholesterol drug for children.
FDA Expands Use Of Regeneron's Children Cholesterol Drug Evkeeza
The FDA has approved the expanded use of Regeneron's drug Evkeeza in children to treat a rare disease that causes high cholesterol.
World Water Day: Tips for Testing and Filtering at Home
Riggs Eckelberry, CEO of OriginClear, which manufactures modular clean water systems, provided background on the water safety crisis in the U.S. He also provided best practices on how to test and filter water at home.
CDC Warns Of Deadly Fungus
The Centers for Disease Control and Prevention is warning of a rare and mysterious deadly fungal infection that is spreading at an alarming rate around the country.
'Forever Chemical' Exposure Stunts Child Development, Says Study
New research shows that exposure to polyfluoroalkyl substances (PFAS), also known as "forever chemicals" can hamper growth and development in children by "altering hormonal and metabolic pathways."
CDC: Deadly Fungal Infections Spreading at an 'Alarming Rate'
The Centers for Disease Control and Prevention (CDC) on Monday warned that a deadly fungus called Candida auris (C. auris) is spreading at an "alarming rate" in the U.S. healthcare facilities.
One Good Thing: Chuck Lorre's $30M Donation to Open Med School For Underserved Students
One Good Thing: Chuck Lorre's $30M Donation to Open Med School For Underserved Students
Karuna Therapeutics Sees Breakthrough In Schizophrenia Drug
Karuna Therapeutics' top-experimental schizophrenia drug significantly reduced symptoms in a late-stage trial but there were concerns that it could cause hypertension in patients.
